Development of a new weighted ROC (WROC) analysis - Resubmission - 1
Project Number5R01EB034517-02
Former Number1R01EB034517-01
Contact PI/Project LeaderJIANG, YULEI
Awardee OrganizationUNIVERSITY OF CHICAGO
Description
Abstract Text
ABSTRACT
The broad and long-term objective of our research inquiry is to develop receiver operating characteristic (ROC)
analysis towards a broadly applicable, practical, accurate, precise, efficient, and user-friendly method for
evaluation of diagnostic performance in medical imaging and beyond. The objective of this project is to
develop an innovative weighted ROC (WROC) analysis. The central hypothesis is that, by introducing a case
weighting factor, WROC analysis can mitigate and eliminate bias in ROC analysis from non-random case
samples and infer clinical performance without bias. Specific Aims are: (1) develop WROC algorithms and
share analysis software with the research community; (2) develop and validate three WROC analysis
applications; and (3) investigate with WROC analysis pivotal ROC study inference bias from non-random case
samples. Research design, based on contemporary ROC methodologies and preliminary studies, will be to
expand the basic ROC theory by introducing a weight factor to every case, and to develop WROC estimation
algorithms for common ROC models including the non-parametric, conventional binormal, and proper
binormal models, to develop new WROC software, which will supersede existing ROC software, and to make
the new software available to the research community by developing an open, easy-to-use, feature-rich, and
publication-friendly online calculator. New WROC algorithms will be used to develop three new applications:
to compare meaningfully ROC studies of non-random and non-identical case samples, to design ROC studies
with stratified case samples and then apply WROC analysis to model case sample distributions to match
random sampling and infer random-sample ROC performance without bias, and to estimate aggregate ROC
performance of multiple readers by averaging individual-reader ROC curves weighted by clinical case volume.
Finally, WROC analysis will be used to investigate bias in the inference to clinical performance from multi-
reader multi-case (MRMC) studies of non-random case samples and WROC analysis as a means to overcome
this bias. Methods to be used include mathematical derivation of maximum-likelihood estimations, software
development, and validation with Monte Calo simulations. The proposed WROC analysis is premised on
weighing cases unequally. This simple addition of a case weight will add a new dimension to ROC analysis.
Practical benefits include added analysis flexibility, improved clinical performance inference from laboratory
studies, and new ways to design better reader studies. The importance and health relatedness of this research
is that once developed, validated, and made available to and used by the research community, the new
development will be one step that advances ROC analysis towards a broadly applicable, practical, accurate,
precise, efficient, and user-friendly method for diagnostic performance evaluation.
Public Health Relevance Statement
NARRATIVE (RELEVANCE)
Receiver operating characteristic (ROC) analysis is an important methodology and cornerstone of medical
imaging because it is the main tool for evaluating diagnostic performance of radiologists, medical devices, and
new technologies in binary medical decision-making tasks (e.g., diagnosis of a patient as having a cancer vs.
not). This proposal, which we call weighted ROC (WROC) analysis, innovates on basic ROC theory and practical
applications alike by introducing a new case-weight factor, which will add flexibility to ROC analysis, improve
clinical performance inference from laboratory studies, produce new ways to design better studies, and spawn
new future research. WROC analysis will help make ROC analysis more general, broadly applicable, practical,
accurate, precise, efficient, and user-friendly, and will enable it to make greater impact on evaluation and
optimization of medical technologies and medical decision-making.
National Institute of Biomedical Imaging and Bioengineering
CFDA Code
286
DUNS Number
005421136
UEI
ZUE9HKT2CLC9
Project Start Date
01-February-2024
Project End Date
31-December-2027
Budget Start Date
01-January-2025
Budget End Date
31-December-2025
Project Funding Information for 2025
Total Funding
$361,166
Direct Costs
$225,000
Indirect Costs
$136,166
Year
Funding IC
FY Total Cost by IC
2025
National Institute of Biomedical Imaging and Bioengineering
$361,166
Year
Funding IC
FY Total Cost by IC
Sub Projects
No Sub Projects information available for 5R01EB034517-02
Publications
Publications are associated with projects, but cannot be identified with any particular year of the project or fiscal year of funding. This is due to the continuous and cumulative nature of knowledge generation across the life of a project and the sometimes long and variable publishing timeline. Similarly, for multi-component projects, publications are associated with the parent core project and not with individual sub-projects.
No Publications available for 5R01EB034517-02
Patents
No Patents information available for 5R01EB034517-02
Outcomes
The Project Outcomes shown here are displayed verbatim as submitted by the Principal Investigator (PI) for this award. Any opinions, findings, and conclusions or recommendations expressed are those of the PI and do not necessarily reflect the views of the National Institutes of Health. NIH has not endorsed the content below.
No Outcomes available for 5R01EB034517-02
Clinical Studies
No Clinical Studies information available for 5R01EB034517-02
News and More
Related News Releases
No news release information available for 5R01EB034517-02
History
No Historical information available for 5R01EB034517-02
Similar Projects
No Similar Projects information available for 5R01EB034517-02